Key statistics
As of last trade, 10X Genomics Inc (TXG:NSQ) traded at 23.60, 54.42% above the 52 week low of 15.28 set on Jul 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 22.94 |
---|---|
High | 23.79 |
Low | 22.85 |
Bid | 23.58 |
Offer | 23.61 |
Previous close | 22.08 |
Average volume | 1.27m |
---|---|
Shares outstanding | 120.49m |
Free float | 103.41m |
P/E (TTM) | -- |
Market cap | 2.66bn USD |
EPS (TTM) | -2.02 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 16:04 BST.
More ▼
- Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer
- 10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research
- 10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
- 10x Genomics Announces Senior Leadership Changes
- 10x Genomics Reports Second Quarter 2024 Financial Results
- 10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex Diseases
- 10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024
- New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies
More ▼